MTOR and uveitis: mTOR inhibition was found to be effective in the treatment of uveitis – intraocular inflammatory condition – uveitis [25], as well as in experimental models of various eye diseases with neovascular component, suggesting that mTOR is a prospective target for the treatment of CNV [20, 26, 27].